AGA affects up to 80 per cent of men across their lifetime and remains one of the most common and most psychologically challenging forms of hair loss
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
The company says those insights can power advanced analytics and real-world evidence (RWE), helping researchers improve trial design, study feasibility, and recruitment strategies
The study will test the company’s lead product, ZI-MA4-1, in patients with advanced solid cancers
Ryght AI tackles these hurdles with its AI Site Twin platform
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Opaganib has shown potential in enhancing ARPI treatment by blocking multiple enzymes involved in cancer cell survival.
Subscribe To Our Newsletter & Stay Updated
